A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain
Clinical trial NCT00662558 · COMPLETED
Trial details
- NCT number
- NCT00662558
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-09-01
- Enrollment
- 802
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.